OmniActive’s Omnixan-RS Receives Self-Affirmed Gras Status

OmniActive’s OmniXan-RS has received self-affirmed GRAS (Generally Recognised as Safe) notification by an external expert panel who evaluated the ingredient in accordance with stringent US Food and Drug Administration safety criteria. “With the rising interest and science supporting meso-zeaxanthin, OmniXan-RS helps meet a gap for a stand-alone RS-zeaxanthin ingredient in the market,” said Lynda M. Doyle, Sr VP of Global Marketing, OmniActive.


Read More on Nutraceutical Buisiness Review